Premring

Premring is a first-in-class medicated vaginal ring being developed by Arstat Pharmaceuticals for the treatment of uterine fibroids and endometriosis. It utilizes a small molecule selective progesterone receptor modulator (SPRM) delivered through a targeted, controlled intravaginal system. This delivery method is designed to provide low doses of the drug directly to the affected pelvic tissues, aiming to offer a safe and efficacious long-term therapeutic option. By addressing the underlying pathology of these conditions locally, Premring seeks to significantly reduce the symptoms and the eventual need for radical surgical interventions such as hysterectomies.

Brand names

Premring